Professionals 228 results
Capabilities 68 results
Industry
Practice Area
Tax Controversy & Criminal Tax
Industry
Experience 15 results
Experience
|August 1, 2024
Liberty Latin America and Millicom Agree to Combine Operations in Costa Rica
Experience
|June 13, 2024
Winston advises Ardian on its acquisition of a majority stake in Alstef Group
Experience
|April 10, 2024
Winston assists Eurazeo in the financing of Vulcain Ingénierie's fourth LBO
Insights & News 2,277 results
Client Alert
|May 16, 2025
|3 Min Read
CFPB Plans to Close Repeat Offender Registry
Competition Corner
|May 16, 2025
|7 Min Read
In a marked shift toward competition-focused healthcare policy, the latest Executive Order on drug pricing reflects the Administration’s expanding use of antitrust tools to address high pharmaceutical costs. Framed around the “most-favored-nation” principle, this initiative is more than a pricing measure—it signals a broader regulatory agenda that targets market power and pricing disparities long shielded from traditional enforcement. Here’s what companies across the healthcare sector need to know.
Capital Markets & Securities Law Watch
|May 15, 2025
|3 Min Read
House Committee Votes to Abolish Public Company Accounting Oversight Board
On April 30, 2025, the Financial Services Committee of the U.S. House of Representatives voted to advance a draft bill that would abolish the Public Company Accounting Oversight Board (PCAOB) and shift its oversight duties to the SEC.
Other Results 45 results
Site Content
Site Content
What Is the Financial Industry Regulatory Authority (FINRA)?
Site Content
What Is the Securities Exchange Act of 1934?